Clinical Trial

Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma

Study acronym: ICE-SECRET
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 6, 2026 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This experiment is designed for post marketing data collection of a cryosurgical system \[PROSENSE™ of IceCure Medical\], for the treatment of renal cell carcinoma (RCC).
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2015-03-25; most recent amendment 2026-01-01.
Status change: Recruiting → Active, Not Recruiting 2021-05-31
Trial Details
NCT Number NCT02399124
Lead Sponsor IceCure Medical Ltd.
Collaborators: Bnai Zion Medical Center, Assaf-Harofeh Medical Center
Conditions Renal Cell Carcinoma
Enrollment 120 participants
Start Date 2014-07
Primary Completion 2026-02 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-06